Exagen
XGN
54 hedge funds and large institutions have $129M invested in Exagen in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 11 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 16
3.77% less ownership
Funds ownership: 54.65% → 50.88% (-3.8%)
5% less funds holding
Funds holding: 57 → 54 (-3)
17% less capital invested
Capital invested by funds: $156M → $129M (-$27.1M)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$4.98M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$4.64M |
| 3 |
CAC
Cowen and Company
New York
|
+$4.21M |
| 4 |
Morgan Stanley
New York
|
+$4.08M |
| 5 |
BCI
Brinker Capital Investments
Berwyn,
Pennsylvania
|
+$1.84M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RI
RTW Investments
New York
|
-$12.3M |
| 2 |
PVI
Pura Vida Investments
New York
|
-$4.29M |
| 3 |
PGM
Parian Global Management
Pound Ridge,
New York
|
-$3.37M |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$3.01M |
| 5 |
EP
Eversept Partners
New York
|
-$1.83M |
XGN Hedge Fund Activity: Q2 2021 in Review
54 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Exagen (XGN) for Q2 2021, worth a combined $129M — down 17% from $156M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of XGN and 8 opened new positions — a net loss of 3 holders — while 16 trimmed existing stakes and 26 added.
The largest buyer was BlackRock, adding an estimated $4.98M. The largest seller was RTW Investments, cutting an estimated $12.3M.
- 54 institutional investors held Exagen (XGN) as of Q2 2021, down from 57 in Q1 2021.
- Funds reported $129M of Exagen stock for Q2 2021, down 17% quarter-over-quarter.
- 8 funds opened new Exagen positions in Q2 2021 and 11 closed out, a net change of -3 holders.
- The largest Exagen buyer in Q2 2021 was BlackRock, an estimated $4.98M added.
- The largest Exagen seller in Q2 2021 was RTW Investments, an estimated $12.3M sold.
Based on aggregated 13F filings for Q2 2021.